Summary Subclinical sleep apnea represents the often-overlooked middle ground between benign snoring and clinically diagnosed obstructive sleep apnea (OSA). Though these patients may not meet the standard AHI ≥ 5 threshold, they frequently experience measurable physiological disruptions — including flow-limited breathing, mild oxygen desaturations, and fragmented sleep. These subtle patterns contribute to increased cardiovascular strain, metabolic dysregulation, and cognitive impairment long before overt disease appears. Traditional single-night polysomnography often misses these early deviations, leaving at-risk patients undiagnosed until symptoms or comorbidities worsen. Advancements in medical-grade home sleep testing (HSAT) are changing that trajectory. By capturing true respiratory effort, oxygenation, and...
Featured Articles
Home Sleep Apnea Tests (HSATs) are...
READ
This in-depth interview with Dr. Atul...
READ
This article explores how oral GLP-1...
READthe WESPER JOURNAL
Discover Our
Clinical Validations
Wesper’s technology is backed by rigorous clinical validations, ensuring accuracy and reliability in sleep health monitoring. Tested against gold-standard sleep studies, Wesper delivers precise data on sleep quality, stages, snoring, and breathing patterns, providing both patients and providers with trusted insights for effective sleep management.
GETTING TO KNOW OUR SLEEP EXPERT
Questions? Dr. Rohrscheib has Answers.
Struggling with undiagnosed sleep apnea? You’ve come to the right place. Dr. Chelsie Rohrscheib, our in-house sleep expert and researcher, provides valuable educational content on conditions associated with sleep apnea and how Wesper can offer solutions to help you take control of your sleep health.
provider portal
Watch our youtube shorts now